December 2002
Volume 43, Issue 13
Free
ARVO Annual Meeting Abstract  |   December 2002
The Age-related Macular Degeneration Radiotherapy Trial (AMDRT): Baseline Characteristics
Author Affiliations & Notes
  • DM Marcus
    Departments of Ophthalmology Medical College of Georgia Augusta GA
  • MG Maguire
    Scheie Eye Institute University of Pennsylvania Philadelphia PA
  • AM Maguire
    Scheie Eye Institute University of Pennsylvania Philadelphia PA
  • SL FineAMDRT Study Group
    Scheie Eye Institute University of Pennsylvania Philadelphia PA
  • Footnotes
    Commercial Relationships   D.M. Marcus, None; M.G. Maguire, None; A.M. Maguire, None; S.L. Fine, None. Grant Identification: Research to Prevent Blindness
Investigative Ophthalmology & Visual Science December 2002, Vol.43, 1207. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      DM Marcus, MG Maguire, AM Maguire, SL FineAMDRT Study Group; The Age-related Macular Degeneration Radiotherapy Trial (AMDRT): Baseline Characteristics . Invest. Ophthalmol. Vis. Sci. 2002;43(13):1207.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose: To describe the baseline characteristics of eyes enrolled in the AMDRT. Methods: Eleven centers enrolled 89 patients in the AMDRT, a randomized clinical pilot trial assessing the efficacy of external beam irradiation (5 x 4 Gy fractions=20Gy; 6 MeV) versus observation in the treatment of new and recurrent subfoveal choroidal neovascularization (CNV) in AMD. Eligibility criteria include visual acuity ≷20/320 and CNV not amenable to MPS laser treatment or photodynamic therapy with verteporfin. Primary outcome measures are change in visual acuity. Secondary outcome measures are fluorescein angiographic response and incidence of side effects. Results: Eighty patients demonstrate new CNV and 9 patients demonstrate recurrent CNV. At baseline, the radiation and observation groups are not different with respect to age (mean 77), gender (57% males and 63% females), race (100% caucasian), and hypertensive status. Baseline visual acutiy is not different (p<0.33) between the groups (45%≷20/80). Flourescein angiographic features are not different between the groups (85% minimally classic or occult CNV; 71% comprised of 25% blood; 80% comprised of <25% fibrosis). Conclusion: The AMDRT will determine if trends exist for a beneficial radiotherapy effect at a dose of 5 x 4 Gy.

Keywords: 308 age-related macular degeneration • 357 clinical (human) or epidemiologic studies: treatment/prevention assessment/controlled clinical trials • 538 radiation therapy 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×